All currency values in $ millions unless otherwise noted
Scroll
| Income Statement | TTM | JAN 2026 | JAN 2025 | JAN 2024 | JAN 2023 | JAN 2022 ~2.7:1 split |
|---|---|---|---|---|---|---|
| Revenues | ||||||
| Revenue | $1,721 | $1,611 | $1,430 | $1,308 | $1,059 | $892 |
| Cost of Revenue | $300 | $271 | $247 | $196 | $180 | $169 |
| Gross Profit | $1,421 | $1,340 | $1,183 | $1,112 | $879 | $723 |
| Operating Expenses | ||||||
| Selling & Marketing | $690 | $683 | $738 | $713 | $702 | $698 |
| General & Administrative | $209 | $214 | $226 | $232 | $240 | $250 |
| Research & Development | $368 | $385 | $381 | $332 | $286 | $277 |
| Provision for Doubtful Accounts | – | $6 | $2 | -$2 | $1 | $1 |
| Total Operating Expenses | $1,268 | $1,283 | $1,345 | $1,277 | $1,227 | $1,224 |
| Operating Income | $153 | $57 | -$163 | -$165 | -$348 | -$501 |
| Non-Operating | ||||||
| Net Interest Expense | $45 | $48 | $49 | $57 | $28 | $4 |
| Other Non-Operating Income (Expense) | $13 | -$4 | $35 | $32 | $3 | -$13 |
| EBT (Earnings Before Tax) | $211 | $101 | -$78 | -$76 | -$318 | -$511 |
| Income Tax Expense | -$151 | -$182 | -$4 | $14 | $11 | $15 |
| Net Income | ||||||
| Net Income | $362 | $282 | -$74 | -$90 | -$328 | -$526 |
| Per Share Data | ||||||
| Revenue Per Share | $3.29 | $2.96 | $2.55 | $2.32 | $1.93 | $1.96 |
| EPS (Basic) | $0.67 | $0.52 | -$0.13 | -$0.16 | -$0.60 | -$1.16 |
| EPS (Diluted) | $0.67 | $0.52 | -$0.13 | -$0.16 | -$0.60 | -$1.16 |
| Weighted Avg Shares (Basic) | 519.7M | 538.1M | 559.9M | 563.9M | 548.0M | 454.6M |
| Weighted Avg Shares (Diluted) | 523.0M | 544.9M | 559.9M | 563.9M | 548.0M | 454.6M |
| Shares Outstanding | 523.0M | 544.9M | 559.9M | 563.9M | 548.0M | 454.6M |
UiPath (PATH) financials: revenue, profit and margins
UiPath (PATH) generated about $1.7 billion in revenue and $362 million in net income (a 21.0% net margin) over the trailing twelve months, growing at roughly 21.5% a year. Figures are from SEC filings; this is analysis, not investment advice.
Frequently asked
What is UiPath's (PATH) revenue?+
UiPath generated about $1.7 billion in revenue over the trailing twelve months. Revenue has grown at roughly 21.5% a year over the past five years. Revenue is the top line, before any costs; what matters for value is how much of it survives to free cash flow. The full income statement, balance sheet and cash-flow statement are on this tab.
Is UiPath profitable?+
Yes, UiPath reported about $362 million in net income over the trailing twelve months, a net profit margin of roughly 21.0%. Net income is the bottom line after all costs, interest and taxes. Compare it to free cash flow on this tab, since reported profit and actual cash generated can diverge.
What are UiPath's profit margins?+
UiPath runs a gross margin of about 82.6%, an operating margin of about 8.9%, a net margin of about 21.0%. Margins show how much of each sales dollar a company keeps at each stage. Stable or rising margins usually signal pricing power and cost discipline; falling margins are worth investigating. See the multi-year trend on this tab.
How fast is UiPath growing?+
UiPath's revenue has compounded at roughly 21.5% a year over the past five years. Growth only creates value when it is profitable and cash-generative, so read this rate alongside PATH's margins and free cash flow. This is analysis from SEC filings, not investment advice.
SourceFinancial statements computed from the 10-Q filed 8 Sept 2026, covering the period ending 31 Jul 2026, as reported to the SEC. Data last refreshed 9 Sept 2026. How this is calculated.
Fiscal year ends Jan.
Peers
Services-Prepackaged Software · Pick stocks to compare with PATH
Held by ETFs
PATH is in 120 US ETFs. The largest of them, with PATH's weight in each:
Vanguard Total Stock Market ETFVTI0.01%of the fund
Vanguard Small-Cap ETFVB0.07%of the fund
Vanguard Information Technology ETFVGT0.05%of the fund
iShares Core S&P Mid-Cap ETFIJH0.17%of the fund
Vanguard Extended Market ETFVXF0.06%of the fund
iShares Core S&P Total U.S. Stock Market ETFITOT0.01%of the fund
Spot a number that looks wrong? Check it in PATH's SEC filings or
Download this analysis as a PDF (Pro)
Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.
Keep analysing PATH
Create a free account and get 14 days of Premium: every stock and every tool.
- Unlimited stocks
- Stock screener
- Portfolio tracker
- Editable DCF
- Compare side by side
- Unlimited alerts
No card. Moves to Free after, unless you upgrade.
Already have an account?
Or come back tomorrow. Stocks on your watchlist are always free to view.